US 12006340
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
granted A61KA61K31/7076A61K31/708
Quick answer
US patent 12006340 (Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus) held by Atea Pharmaceuticals, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/7076, A61K31/708, A61K45/06, A61K9/20